Cancer Immunotherapy Archives - Oncology Nurse Advisor

Cancer Immunotherapy

HF/CM risks in breast chemotherapy

HF/CM risks in breast chemotherapy

Earlier study findings that anthracycline- or trastuzumab-based treatment for breast cancer raises the risk for heart failure and cardiomyopathy can be extended to a more general population of women.

Next post in Web Exclusives